Letteratura scientifica selezionata sul tema "Daunorubicin"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Daunorubicin".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Daunorubicin"
Drevin, Guillaume, Marie Briet, Caroline Bazzoli, et al. "Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial." Pharmaceutics 14, no. 4 (2022): 792. http://dx.doi.org/10.3390/pharmaceutics14040792.
Testo completoZucchetti, Massimo, Amerigo Boiardi, Antonio Silvani, Idria Parisi, Stefano Piccolrovazzi, and Maurizio D'Incalci. "Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin." Cancer Chemotherapy and Pharmacology 44, no. 2 (1999): 173–76. http://dx.doi.org/10.1007/s002800050964.
Testo completo&NA;. "Daunorubicin see Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 354 (1991): 8. http://dx.doi.org/10.2165/00128415-199103540-00027.
Testo completoChoi, Min-Koo, Im-Sook Song, Dae-Duk Kim, Suk-Jae Chung, and Chang-Koo Shim. "Altered Pharmacokinetics of Daunorubicin in Rats with CCl4-Induced Hepatic Injury." Journal of Pharmacy & Pharmaceutical Sciences 10, no. 4 (2007): 443. http://dx.doi.org/10.18433/j3mw28.
Testo completoCusack, B. J., Stephan P. Young, Robert E. Vestal, and Richard D. Olson. "Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat." Cancer Chemotherapy and Pharmacology 39, no. 6 (1997): 505–12. http://dx.doi.org/10.1007/s002800050606.
Testo completoNikanjam, Mina, Edmund Capparelli, Jeffrey E. Lancet, Jonathan E. Kolitz, Arthur C. Louie, and Gary J. Schiller. "Enhanced Cytarabine and Daunorubicin Population Pharmacokinetics When Administered As CPX-351: A Novel Liposomal Formulation Not Requiring Dose Reduction for Mild Renal or Hepatic Dysfunction." Blood 128, no. 22 (2016): 3955. http://dx.doi.org/10.1182/blood.v128.22.3955.3955.
Testo completoAlves, Ana Catarina, Daniela Ribeiro, Miguel Horta, José L. F. C. Lima, Cláudia Nunes, and Salette Reis. "A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity." Journal of The Royal Society Interface 14, no. 133 (2017): 20170408. http://dx.doi.org/10.1098/rsif.2017.0408.
Testo completoAlbrecht, K. W., S. Leenstra, P. J. M. Bakker, et al. "High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin." Clinical Neurology and Neurosurgery 99 (July 1997): S231. http://dx.doi.org/10.1016/s0303-8467(97)82346-3.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1184 (2008): 15. http://dx.doi.org/10.2165/00128415-200811840-00044.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 562 (1995): 6. http://dx.doi.org/10.2165/00128415-199505620-00017.
Testo completoTesi sul tema "Daunorubicin"
Golightly, L. "Trypanosmoma brucei : Studies on the uptake and effects of daunorubicin and daunorubicin carrier preparations." Thesis, University of Sunderland, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.375648.
Testo completoHardman, Mark Alan. "Design of potential antiprotozoal daunorubicin derivatives." Thesis, De Montfort University, 1985. http://hdl.handle.net/2086/10737.
Testo completoMohammed, Lina Yousif. "Studies on daunorubicin and actinorhodin type II polyketide synthases." Thesis, University of Bristol, 2018. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.761209.
Testo completoWattana-Amorn, Pakorn. "Studies on the actinorhodin and daunorubicin type II polyketide synthases." Thesis, University of Bristol, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.441375.
Testo completoBartels, Anna-Maria. "Durchflusszytometrische Untersuchungen zur zellulären Pharmakokinetik von freien und liposomal verkapseltem Daunorubicin." [S.l.] : [s.n.], 2002. http://deposit.ddb.de/cgi-bin/dokserv?idn=965428001.
Testo completoMaharaj, Vanitha. "A vibrational circular dichroism study of deoxyoctanucleotides and their daunorubicin complexes." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/nq20751.pdf.
Testo completoBartels, Anna-Maria. "Durchflußzytometrische Untersuchungen zur zellulären Pharmakokinetik von freien und liposomal verkapseltem Daunorubicin." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2002. http://dx.doi.org/10.18452/14780.
Testo completoBattisti, Robert F. "Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance." Connect to resource, 2007. http://hdl.handle.net/1811/25067.
Testo completoMasquelier, Michèle. "Leukemia chemotherapy : experimental studies on pharmacological optimisation /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-046-X/.
Testo completoKnaust, Eva. "Experimental studies on multidrug resistance in human leukaemia : role of cellular heterogeneity for daunorubicin kinetics /." Linköping : Dept. of Medicine and Care, Univ, 2005. http://www.bibl.liu.se/liupubl/disp/disp2005/med901s.pdf.
Testo completoLibri sul tema "Daunorubicin"
Hardman, Mark Alan. Design of potential antiprotozoal daunorubicin derivatives. Leicester Polytechnic, 1985.
Cerca il testo completoEikel, Daniel. Entwicklung Eines Bestimmungsverfahrens Für Liposomal Verkapseltes Daunorubicin. Diplomarbeiten Agentur diplom.de. ein Imprint der Diplomica, 2001.
Cerca il testo completoSteidtmann, Kay. Veränderungen von Morphologie und Wachstum zweier humaner Tumorzellinien in vitro induzierter Daunorubicin-Resistenz. 1991.
Cerca il testo completoBöhm, Dania. Aufnahme von I-123- und Tc-99m-Doxorubicin verglichen mit Tl-201 in Daunorubicin-sensitive und -resistente Magenkarzinomzellen. 1998.
Cerca il testo completoCapitoli di libri sul tema "Daunorubicin"
Mader, Ines, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin." In Paravasation von Zytostatika. Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-3799-4_19.
Testo completoMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Daunorubicin." In Extravasation of Cytotoxic Agents. Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_26.
Testo completoMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin." In Extravasation of Cytotoxic Agents. Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_19.
Testo completoMader, Ines, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin liposomal." In Paravasation von Zytostatika. Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-3799-4_20.
Testo completoMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Daunorubicin liposomal." In Extravasation of Cytotoxic Agents. Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_27.
Testo completoMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin liposomal." In Extravasation of Cytotoxic Agents. Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_20.
Testo completoMartin, R. Bruce. "Tetracyclines and Daunorubicin." In Metal Ions in Biological Systems. CRC Press, 2024. http://dx.doi.org/10.1201/9781003573630-2.
Testo completoChaires, Jonathan B. "Molecular Recognition of DNA by Daunorubicin." In ACS Symposium Series. American Chemical Society, 1994. http://dx.doi.org/10.1021/bk-1995-0574.ch010.
Testo completoShrestha, Biplav, Anaya Raj Pokhrel, Sumangala Darsandhari, Prakash Parajuli, Jae Kyung Sohng, and Ramesh Prasad Pandey. "Engineering Streptomyces peucetius for Doxorubicin and Daunorubicin Biosynthesis." In Environmental Chemistry for a Sustainable World. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-01881-8_7.
Testo completoKnaust, E., A. Gruber, A. Porwit-MacDonald, and C. Peterson. "Functional Studies of Daunorubicin Transport in Human Leukemic Cells." In Haematology and Blood Transfusion / Hämatologie und Bluttransfusion. Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-71960-8_68.
Testo completoAtti di convegni sul tema "Daunorubicin"
Sheng, Xia, Jean-Hugues Parmentier, Jonathan Tucci, et al. "Abstract 2960: Adipocytes sequester and metabolize daunorubicin." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-2960.
Testo completoRios-Doria, Jonathan, Tara L. Costich, Adam Carie, and Kevin Sill. "Abstract 4453: Development of a crosslinked, daunorubicin-loaded micelle with superior pharmacokinetics compared to free daunorubicin and with tunable stability." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4453.
Testo completoOsdal, Tereza, Lars P. Jordheim, Mihaela Popa, et al. "Abstract 3274: Combination of elacytarabine and daunorubicin is significantly more effective than combination of cytarabine and daunorubicin in primary patient xenografts of AML." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-3274.
Testo completoSheng, Xia, Jonathan Tucci, James Behan, and Steven D. Mittelman. "Abstract 172: Adipocytes decrease daunorubicin concentration in acute lymphoblastic leukemia cells." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-172.
Testo completoParmentier, Jean-Hugues, Christina M. Dieli-Conwright, and Steven D. Mittelman. "Abstract 3185: Adipocyte-derived hydrogen peroxide promotes chemoresistance to daunorubicin in leukemia cells." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3185.
Testo completoZahariev, Nikolay, and Bissera Pilicheva. "Development of casein-fucoidan nanocomposites as a potential drug delivery system for daunorubicin." In VI. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2024. http://dx.doi.org/10.14232/syrptbrs.2024.39.
Testo completoSheng, Xia, Jonathan Tucci, and Steven D. Mittelman. "Abstract 1247: Reduction of oxidative stress promotes daunorubicin resistance in acute lymphoblastic leukemia cells." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1247.
Testo completoCostich, Tara Lee, Rick Crouse, Adam Carie, et al. "Abstract 1317: IT-143: A nanoparticle delivery platform that encapsulates daunorubicin and widens therapeutic window." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1317.
Testo completoContente, Thais C., Iara F. Kretzer, Durvanei A. Maria, Tathiana Capeto, Ricardo Fock, and Raul C. Maranhao. "Abstract 2656: Association of daunorubicin to a lipidic nanoemulsion (NEM-ODNR) - in vivo tumor growth inhibition." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2656.
Testo completoLin, Tara L., John M. Perry, Xi He, et al. "Abstract CT103: Low-dose daunorubicin to target leukemia stem cells in newly diagnosed and relapsed/refractory AML." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-ct103.
Testo completo